[Therapy of chronic inflammatory intestinal disease].
Van Gossum
A
A
Service de Gastro-entérologie, Hôpital Erasme, U.L.B.
D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D019819:Budesonide / Q000627:therapeutic use; D002908:Chronic Disease; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000628:therapy*; D003424:Crohn Disease / Q000628:therapy*; D016572:Cyclosporine / Q000627:therapeutic use; D004338:Drug Combinations; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005944:Glucosamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D012460:Sulfasalazine / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D004338:Drug Combinations; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; C028423:Salazopyrine; D012460:Sulfasalazine; D019819:Budesonide; D016572:Cyclosporine; D000069285:Infliximab; D001379:Azathioprine; D005944:Glucosamine
Stratégie thérapeutique dans les maladies inflammatoires chroniques de l'intestin.